Evidence map›Paper›PMID 28464847›Full record

ArticleBMC infectious diseases2017

Glycosaminoglycans are involved in bacterial adherence to lung cells.

Olga Rajas, Luis M Quirós, Mara Ortega, Emma Vazquez-Espinosa, Jesús Merayo-Lloves, Fernando Vazquez, Beatriz García

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Pathogens that infect mammalian cells via sulfonated glycosaminoglycans.Frontiers in cellular and infection microbiology · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Trimeric Autotransporter Adhesin YadA ofFrontiers in microbiology · 2021
    Article
  11. Review
  12. Interaction ofMatrix biology plus · 2020
    Article
  13. Syndecans in Inflammation at a Glance.Frontiers in immunology · 2020
    Review
  14. Epithelial Heparan Sulfate Contributes to Alveolar Barrier Function and Is Shed during Lung Injury.American journal of respiratory cell and molecular biology · 2018
    Article
  15. The consequence of matrix dysfunction on lung immunity and the microbiome in COPD.European respiratory review : an official journal of the European Respiratory Society · 2018
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Olga RajasPneumology Service, Hospital La Princesa, Institute for Health Research (IP), Hospital Universitario de La Princesa, Madrid, Spain.
Luis M QuirósUniversity Institute Fernandez-Vega (IUFV), University of Oviedo and Eye Research Foundation (FIO), Oviedo, Spain.
Mara OrtegaBiobank Coordinator, Institute for Health Research (IP), Hospital Universitario de La Princesa, Madrid, Spain.
Emma Vazquez-EspinosaPneumology Service, Hospital La Princesa, Institute for Health Research (IP), Hospital Universitario de La Princesa, Madrid, Spain.
Jesús Merayo-LlovesUniversity Institute Fernandez-Vega (IUFV), University of Oviedo and Eye Research Foundation (FIO), Oviedo, Spain.
Fernando VazquezUniversity Institute Fernandez-Vega (IUFV), University of Oviedo and Eye Research Foundation (FIO), Oviedo, Spain.
Beatriz GarcíaUniversity Institute Fernandez-Vega (IUFV), University of Oviedo and Eye Research Foundation (FIO), Oviedo, Spain. garciabeatriz@uniovi.es.ORCID 0000-0002-5235-5167
Universidad de Oviedo · ESHospital Universitario de La Princesa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLower respiratory infections are among the top ten causes of death worldwide. Since pathogen to cell adhesion is a crucial step in the infection progress, blocking the interaction between eukaryotic receptors and bacterial ligands may enable the pathogenesis process to be stopped. Cell surface glycosaminoglycans (GAGs) are known to be mediators in the adhesion of diverse bacteria to different cell types, making it of interest to examine their involvement in the attachment of various pathogenic bacteria to lung cells, including epithelial cells and fibroblasts.

methodsThe function of cell surface GAGs in bacterial adhesion was studied by reducing their levels through inhibiting their biosynthesis and enzymatic degradation, as well as in binding competition experiments with various species of GAGs. The participation of the different bacterial adhesins in attachment was evaluated through competition with two peptides, both containing consensus heparin binding sequences. Blocking inhibition assays using anti-syndecans and the enzymatic removal of glypicans were conducted to test their involvement in bacterial adhesion. The importance of the fine structure of GAGs in the interaction with pathogens was investigated in competition experiments with specifically desulfated heparins.

resultsThe binding of all bacteria tested decreased when GAG levels in cell surface of both lung cells were diminished. Competition experiments with different types of GAGs showed that heparan sulfate chains are the main species involved. Blocking or removal of cell surface proteoglycans evidenced that syndecans play a more important role than glypicans. The binding was partially inhibited by peptides including heparin binding sequences. Desulfated heparins also reduced bacterial adhesion to different extents depending on the bacterium and the sulfated residue, especially in fibroblast cells.

conclusionsTaken together, these data demonstrate that the GAG chains of the cell surface are involved in the adhesion of bacterial adhesins to lung cells. Heparan sulfate seems to be the main species implicated, and binding is dependent on the sulfation pattern of the molecule. These data could facilitate the development of new anti-infective strategies, enabling the development of new procedures for blocking the interaction between pathogens and lung cells more effectively.

Indexed as

Bacterial AdhesionCell LineEpithelial CellsFibroblastsGlycosaminoglycansGram-Positive BacteriaHeparan SulfateHeparinHumansLungProteoglycansGlycosaminoglycansHeparan SulfateHeparinProteoglycansGlycosaminoglycansHost interactionInfectionLung cellsPathogenic bacteria

Identifiers

PMID28464847
PMCPMC5414233
OpenAlexW2611338861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.